Global Brazil Veterinary Vaccines Market by Product (Inactivated, Live Attenuated, Recombinant), by Animal Type (Fish, Swine, Poultry, Ruminants) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
Brazil's veterinary vaccines market was worth USD 435.3 millions in 2019. It is expected to grow at a 6.4% compound annual growth rate (CAGR), between 2020 and 2027. Market growth is expected to be driven by two main factors: rising vaccination mandates to combat livestock disease outbreaks, and an increasing demand for livestock-related foods products.
In 2019, the U.S. ranked second in broiler meat output. Brazil is expected to grow its meat export market due to the massive spread of COVID-19 among livestock-producing countries like China and the U.S. Due to the COVID-19 pandemic, Brazilian livestock production will increase by almost 5% in 2020.
Revenue growth is likely to be boosted by favorable government initiatives. In May 2018, for example, the World Organization for Animal Health declared Brazil free from foot and mouth disease (FMD) through vaccination. The National Program for the Eradication and Prevention of FMD decreased the disease vaccine dose from five to two mL and plans to completely withdraw the vaccine by 2021.
The market is also growing because of the increase in companion animals. Abinpet reports that Brazil had 52 million dogs, making it the largest country in Latin America. The market is also growing due to the increasing popularity of animal-assisted therapies. Animal-assisted therapies have been reported to be beneficial for people with autism spectrum disorder, attention deficit disorder, and Cerebral Vascular Accident (CVA). The vaccination market is growing due to increasing concerns about pet health.
Product Insights
The market was dominated by live vaccines in 2019, with more than 40% of the market. This is due to mass vaccination. Live vaccines that are attenuated have been in use for decades. They are the most common method of immunization against transmissible gastroenteritis virus and porcine epidemic diarrhea virus. Ceva's 2017 launch of CEVAC IIBras, the first live attenuated vaccine for the Brazilian avian infectious bronchitis virus, was a success. The fastest expected CAGR for recombinant vaccines is in the forecast period.
This is due to the vaccine's advantages, such as a lower risk of pathogenicity or targeted action. Some strains of Histophilus have been successfully treated with recombinant vaccines. This pathogen is a major threat to the cattle industry. It can cause respiratory diseases, septicemias, reproductive disorders, infectious thrombotic meingoencephalitis, and pleuritic. The vaccines can also be used to treat Rhipicephalus microplus, which is a disease that affects Brazil, Argentina and Peru as well as Uruguay, Venezuela, and other Latin American countries.
Information on Animal Types
The market's largest segment, the ruminant segment, accounted for more than 57% of the total market share in 2019. The segment's growth is expected to be driven by increasing cattle production and government initiatives to stop sudden epidemics of disease. Brazil was the second-largest producer of cattle in the world in 2019.
Improved pasture conditions and crossbreeding are the main drivers of cattle production. India was the country's top exporter of beef in 2019. The country's livestock production was also increased by the 2017 outbreak of African swine flu in Asia. Brazil's veterinary vaccines market is also growing due to the favorable exchange rates, which make it cheaper to import inputs such as vaccines.
Due to the high production of broiler beef in the country, the poultry segment will see the most rapid growth over the forecast period. In 2019, it was the second-largest producer of broiler meat in the world. In 2019, it produced 13.8 million tonnes of broiler meat. It is also the largest exporter of broiler beef in the world. To reduce sudden outbreaks in the poultry industry, MAPA enforces strict regulations. This is further driving segment growth.
Market Share Insights & Key Companies
The market is home to many domestic and foreign companies. Market participants have many growth opportunities because of the country's largest cattle herd. The companies have taken several strategic initiatives such as mergers & acquisitions and product launches, as well the establishment of new manufacturing plants.
Sumitomo Corp., for example, entered into a strategic partnership in October 2018 with Ourofino Saude Animal to grow its veterinary medicine business. Ceva acquired Hertape SaudeAnimale Ltda in Brazil in 2017 to enter the FMD vaccination market in Brazil. Inova Biotecnologia Saude Animale Ltda. To increase market penetration, Boehringer Ingelheim purchased Merial in 2017. These are some of the most prominent players in Brazil's veterinary vaccines market:
-
Zoetis, Inc.
-
Ceva Sante Animale
-
Boehringer Ingelheim
-
MSD Animal Health
Up Market Research published a new report titled “Brazil Veterinary Vaccines Market research report which is segmented by Product (Inactivated, Live Attenuated, Recombinant), by Animal Type (Fish, Swine, Poultry, Ruminants), By Players/Companies MSD Animal Health, Zoetis Inc, Boehringer Ingelheim, Ceva Sant© Animale”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Brazil Veterinary Vaccines Market Research Report |
| By Product | Inactivated, Live Attenuated, Recombinant |
| By Animal Type | Fish, Swine, Poultry, Ruminants |
| By Companies | MSD Animal Health, Zoetis Inc, Boehringer Ingelheim, Ceva Sant© Animale |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 242 |
| Number of Tables & Figures | 170 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Brazil Veterinary Vaccines Market Report Segments:
The market is segmented by Product (Inactivated, Live Attenuated, Recombinant), by Animal Type (Fish, Swine, Poultry, Ruminants).
Brazil Veterinary Vaccines Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Brazil Veterinary Vaccines Market
Overview of the regional outlook of the Brazil Veterinary Vaccines Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Brazil Veterinary Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Brazil Veterinary Vaccines Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Inactivated
2. Live Attenuated
3. Recombinant
7. By Animal Type:1. Fish
2. Swine
3. Poultry
4. Ruminants
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Brazil Veterinary Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Brazil Veterinary Vaccines Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Brazil Veterinary Vaccines Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Brazil Veterinary Vaccines Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Brazil Veterinary Vaccines Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Brazil Veterinary Vaccines Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Brazil Veterinary Vaccines Market Size & Forecast, 2018-2028
4.5.1 Brazil Veterinary Vaccines Market Size and Y-o-Y Growth
4.5.2 Brazil Veterinary Vaccines Market Absolute $ Opportunity
Chapter 5 Global Brazil Veterinary Vaccines Market Analysis and Forecast by Product
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Product
5.1.2 Basis Point Share (BPS) Analysis by Product
5.1.3 Absolute $ Opportunity Assessment by Product
5.2 Brazil Veterinary Vaccines Market Size Forecast by Product
5.2.1 Inactivated
5.2.2 Live Attenuated
5.2.3 Recombinant
5.3 Market Attractiveness Analysis by Product
Chapter 6 Global Brazil Veterinary Vaccines Market Analysis and Forecast by Animal Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Animal Type
6.1.2 Basis Point Share (BPS) Analysis by Animal Type
6.1.3 Absolute $ Opportunity Assessment by Animal Type
6.2 Brazil Veterinary Vaccines Market Size Forecast by Animal Type
6.2.1 Fish
6.2.2 Swine
6.2.3 Poultry
6.2.4 Ruminants
6.3 Market Attractiveness Analysis by Animal Type
Chapter 7 Global Brazil Veterinary Vaccines Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Brazil Veterinary Vaccines Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Brazil Veterinary Vaccines Analysis and Forecast
9.1 Introduction
9.2 North America Brazil Veterinary Vaccines Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Brazil Veterinary Vaccines Market Size Forecast by Product
9.6.1 Inactivated
9.6.2 Live Attenuated
9.6.3 Recombinant
9.7 Basis Point Share (BPS) Analysis by Product
9.8 Absolute $ Opportunity Assessment by Product
9.9 Market Attractiveness Analysis by Product
9.10 North America Brazil Veterinary Vaccines Market Size Forecast by Animal Type
9.10.1 Fish
9.10.2 Swine
9.10.3 Poultry
9.10.4 Ruminants
9.11 Basis Point Share (BPS) Analysis by Animal Type
9.12 Absolute $ Opportunity Assessment by Animal Type
9.13 Market Attractiveness Analysis by Animal Type
Chapter 10 Europe Brazil Veterinary Vaccines Analysis and Forecast
10.1 Introduction
10.2 Europe Brazil Veterinary Vaccines Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Brazil Veterinary Vaccines Market Size Forecast by Product
10.6.1 Inactivated
10.6.2 Live Attenuated
10.6.3 Recombinant
10.7 Basis Point Share (BPS) Analysis by Product
10.8 Absolute $ Opportunity Assessment by Product
10.9 Market Attractiveness Analysis by Product
10.10 Europe Brazil Veterinary Vaccines Market Size Forecast by Animal Type
10.10.1 Fish
10.10.2 Swine
10.10.3 Poultry
10.10.4 Ruminants
10.11 Basis Point Share (BPS) Analysis by Animal Type
10.12 Absolute $ Opportunity Assessment by Animal Type
10.13 Market Attractiveness Analysis by Animal Type
Chapter 11 Asia Pacific Brazil Veterinary Vaccines Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Brazil Veterinary Vaccines Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Brazil Veterinary Vaccines Market Size Forecast by Product
11.6.1 Inactivated
11.6.2 Live Attenuated
11.6.3 Recombinant
11.7 Basis Point Share (BPS) Analysis by Product
11.8 Absolute $ Opportunity Assessment by Product
11.9 Market Attractiveness Analysis by Product
11.10 Asia Pacific Brazil Veterinary Vaccines Market Size Forecast by Animal Type
11.10.1 Fish
11.10.2 Swine
11.10.3 Poultry
11.10.4 Ruminants
11.11 Basis Point Share (BPS) Analysis by Animal Type
11.12 Absolute $ Opportunity Assessment by Animal Type
11.13 Market Attractiveness Analysis by Animal Type
Chapter 12 Latin America Brazil Veterinary Vaccines Analysis and Forecast
12.1 Introduction
12.2 Latin America Brazil Veterinary Vaccines Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Brazil Veterinary Vaccines Market Size Forecast by Product
12.6.1 Inactivated
12.6.2 Live Attenuated
12.6.3 Recombinant
12.7 Basis Point Share (BPS) Analysis by Product
12.8 Absolute $ Opportunity Assessment by Product
12.9 Market Attractiveness Analysis by Product
12.10 Latin America Brazil Veterinary Vaccines Market Size Forecast by Animal Type
12.10.1 Fish
12.10.2 Swine
12.10.3 Poultry
12.10.4 Ruminants
12.11 Basis Point Share (BPS) Analysis by Animal Type
12.12 Absolute $ Opportunity Assessment by Animal Type
12.13 Market Attractiveness Analysis by Animal Type
Chapter 13 Middle East & Africa (MEA) Brazil Veterinary Vaccines Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Brazil Veterinary Vaccines Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Brazil Veterinary Vaccines Market Size Forecast by Product
13.6.1 Inactivated
13.6.2 Live Attenuated
13.6.3 Recombinant
13.7 Basis Point Share (BPS) Analysis by Product
13.8 Absolute $ Opportunity Assessment by Product
13.9 Market Attractiveness Analysis by Product
13.10 Middle East & Africa (MEA) Brazil Veterinary Vaccines Market Size Forecast by Animal Type
13.10.1 Fish
13.10.2 Swine
13.10.3 Poultry
13.10.4 Ruminants
13.11 Basis Point Share (BPS) Analysis by Animal Type
13.12 Absolute $ Opportunity Assessment by Animal Type
13.13 Market Attractiveness Analysis by Animal Type
Chapter 14 Competition Landscape
14.1 Brazil Veterinary Vaccines Market: Competitive Dashboard
14.2 Global Brazil Veterinary Vaccines Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 MSD Animal Health
14.3.2 Zoetis Inc
14.3.3 Boehringer Ingelheim
14.3.4 Ceva Sant© Animale
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Brazil Veterinary Vaccines Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Brazil Veterinary Vaccines Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Brazil Veterinary Vaccines Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Brazil Veterinary Vaccines Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Brazil Veterinary Vaccines Market Size & Forecast, 2018-2028
4.5.1 Brazil Veterinary Vaccines Market Size and Y-o-Y Growth
4.5.2 Brazil Veterinary Vaccines Market Absolute $ Opportunity
Chapter 5 Global Brazil Veterinary Vaccines Market Analysis and Forecast by Product
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Product
5.1.2 Basis Point Share (BPS) Analysis by Product
5.1.3 Absolute $ Opportunity Assessment by Product
5.2 Brazil Veterinary Vaccines Market Size Forecast by Product
5.2.1 Inactivated
5.2.2 Live Attenuated
5.2.3 Recombinant
5.3 Market Attractiveness Analysis by Product
Chapter 6 Global Brazil Veterinary Vaccines Market Analysis and Forecast by Animal Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Animal Type
6.1.2 Basis Point Share (BPS) Analysis by Animal Type
6.1.3 Absolute $ Opportunity Assessment by Animal Type
6.2 Brazil Veterinary Vaccines Market Size Forecast by Animal Type
6.2.1 Fish
6.2.2 Swine
6.2.3 Poultry
6.2.4 Ruminants
6.3 Market Attractiveness Analysis by Animal Type
Chapter 7 Global Brazil Veterinary Vaccines Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Brazil Veterinary Vaccines Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Brazil Veterinary Vaccines Analysis and Forecast
9.1 Introduction
9.2 North America Brazil Veterinary Vaccines Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Brazil Veterinary Vaccines Market Size Forecast by Product
9.6.1 Inactivated
9.6.2 Live Attenuated
9.6.3 Recombinant
9.7 Basis Point Share (BPS) Analysis by Product
9.8 Absolute $ Opportunity Assessment by Product
9.9 Market Attractiveness Analysis by Product
9.10 North America Brazil Veterinary Vaccines Market Size Forecast by Animal Type
9.10.1 Fish
9.10.2 Swine
9.10.3 Poultry
9.10.4 Ruminants
9.11 Basis Point Share (BPS) Analysis by Animal Type
9.12 Absolute $ Opportunity Assessment by Animal Type
9.13 Market Attractiveness Analysis by Animal Type
Chapter 10 Europe Brazil Veterinary Vaccines Analysis and Forecast
10.1 Introduction
10.2 Europe Brazil Veterinary Vaccines Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Brazil Veterinary Vaccines Market Size Forecast by Product
10.6.1 Inactivated
10.6.2 Live Attenuated
10.6.3 Recombinant
10.7 Basis Point Share (BPS) Analysis by Product
10.8 Absolute $ Opportunity Assessment by Product
10.9 Market Attractiveness Analysis by Product
10.10 Europe Brazil Veterinary Vaccines Market Size Forecast by Animal Type
10.10.1 Fish
10.10.2 Swine
10.10.3 Poultry
10.10.4 Ruminants
10.11 Basis Point Share (BPS) Analysis by Animal Type
10.12 Absolute $ Opportunity Assessment by Animal Type
10.13 Market Attractiveness Analysis by Animal Type
Chapter 11 Asia Pacific Brazil Veterinary Vaccines Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Brazil Veterinary Vaccines Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Brazil Veterinary Vaccines Market Size Forecast by Product
11.6.1 Inactivated
11.6.2 Live Attenuated
11.6.3 Recombinant
11.7 Basis Point Share (BPS) Analysis by Product
11.8 Absolute $ Opportunity Assessment by Product
11.9 Market Attractiveness Analysis by Product
11.10 Asia Pacific Brazil Veterinary Vaccines Market Size Forecast by Animal Type
11.10.1 Fish
11.10.2 Swine
11.10.3 Poultry
11.10.4 Ruminants
11.11 Basis Point Share (BPS) Analysis by Animal Type
11.12 Absolute $ Opportunity Assessment by Animal Type
11.13 Market Attractiveness Analysis by Animal Type
Chapter 12 Latin America Brazil Veterinary Vaccines Analysis and Forecast
12.1 Introduction
12.2 Latin America Brazil Veterinary Vaccines Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Brazil Veterinary Vaccines Market Size Forecast by Product
12.6.1 Inactivated
12.6.2 Live Attenuated
12.6.3 Recombinant
12.7 Basis Point Share (BPS) Analysis by Product
12.8 Absolute $ Opportunity Assessment by Product
12.9 Market Attractiveness Analysis by Product
12.10 Latin America Brazil Veterinary Vaccines Market Size Forecast by Animal Type
12.10.1 Fish
12.10.2 Swine
12.10.3 Poultry
12.10.4 Ruminants
12.11 Basis Point Share (BPS) Analysis by Animal Type
12.12 Absolute $ Opportunity Assessment by Animal Type
12.13 Market Attractiveness Analysis by Animal Type
Chapter 13 Middle East & Africa (MEA) Brazil Veterinary Vaccines Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Brazil Veterinary Vaccines Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Brazil Veterinary Vaccines Market Size Forecast by Product
13.6.1 Inactivated
13.6.2 Live Attenuated
13.6.3 Recombinant
13.7 Basis Point Share (BPS) Analysis by Product
13.8 Absolute $ Opportunity Assessment by Product
13.9 Market Attractiveness Analysis by Product
13.10 Middle East & Africa (MEA) Brazil Veterinary Vaccines Market Size Forecast by Animal Type
13.10.1 Fish
13.10.2 Swine
13.10.3 Poultry
13.10.4 Ruminants
13.11 Basis Point Share (BPS) Analysis by Animal Type
13.12 Absolute $ Opportunity Assessment by Animal Type
13.13 Market Attractiveness Analysis by Animal Type
Chapter 14 Competition Landscape
14.1 Brazil Veterinary Vaccines Market: Competitive Dashboard
14.2 Global Brazil Veterinary Vaccines Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 MSD Animal Health
14.3.2 Zoetis Inc
14.3.3 Boehringer Ingelheim
14.3.4 Ceva Sant© Animale
Segments Covered in the Report
The global Brazil Veterinary Vaccines market has been segmented based on
By Product
The global Brazil Veterinary Vaccines market has been segmented based on
By Product
- Inactivated
- Live Attenuated
- Recombinant
- Fish
- Swine
- Poultry
- Ruminants
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- MSD Animal Health
- Zoetis Inc
- Boehringer Ingelheim
- Ceva Sant© Animale
Our Clients
Related Reports
Some other reports from this category!
